MedTrace Logo

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

NCT06084195 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-02-12

No results posted yet for this study

Summary

The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance

Conditions

  • High Grade Serous Ovarian Cancer

Interventions

BIOLOGICAL

Blood sample and tissue sample

During the surgery : * Tissus sample : primary tumor and metastasis * blood sample : 3 EDTA tubes * ex vivo MRI data

Sponsors & Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

    lead OTHER

Principal Investigators

  • NOUGARET Stephanie, MD · INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-19
Primary Completion
2026-10-31
Completion
2029-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06084195 on ClinicalTrials.gov